December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Inhibitory Effect of Angiotensin Converting Enzyme Inhibitors on Retinal Neovascularization
Author Affiliations & Notes
  • H Yamada
    Ophthalmology Kansai Medical University Moriguchi Japan
  • E Yamada
    Ophthalmology Kansai Medical University Moriguchi Japan
  • Y Yamazaki
    Ophthalmology Kansai Medical University Moriguchi Japan
  • M Matsumura
    Ophthalmology Kansai Medical University Moriguchi Japan
  • Footnotes
    Commercial Relationships   H. Yamada, None; E. Yamada, None; Y. Yamazaki, None; M. Matsumura, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1273. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Yamada, E Yamada, Y Yamazaki, M Matsumura; Inhibitory Effect of Angiotensin Converting Enzyme Inhibitors on Retinal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1273.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Angiotensin Converting Enzyme Inhibitor (ACE-I) is used all over the world to control hypertension. Its clinical advantage is that it not only reduces blood pressure but also improves the prognosis of patients after cardiac or cerebral infarction by a vascular remodeling effect. There have been several reports on the anti-neovascular effects of ACE-I. We studied the efficacy of ACE-I on retinal neovascularization (NV). Methods: To induce retinal NV by hypoxic retinopathy, C57bl mice were kept under 75% oxygen for 5 days, from P7 to P12, then moved to a normoxic environment for 5 days. We administered 30 mg/kg Atenolol (b blocker), 30 mg/kg Amlodipine (Ca blocker), 20 mg/kg Enalapril (ACE-I), 2 mg/ml Perindopril (ACE-I), 20 mg/kg Perindopril, or vehicle only (dH2O) to the mice once a day for 5 days. Animals were sacrificed at P17 and perfused with fluorescein dextran through the left ventricle before enucleation or were enucleated immediately, and the eyes were prepared for cryotome sectioning. Fluorescein-dextran-perfused eyeballs were fixed in buffered formalin. Retinae were dissected, flat-mounted on slide glass, and observed under a fluorescein microscope. Non-perfusion areas (NPA) were evaluated using ImagePro software. Cryo-sectioned eyeballs were stained immunohistochemically by Griffonia simpliciforia isolectin-B4 and the NV beneath the retina was evaluated. Results: Mice administered Atenolol, Amlodipine, and vehicle only showed large NPA in the retina and massive retinal NV of almost the same size.Mice administered Enalapril, 2 mg/kg Perindopril, and 20 mg/kg Perindopril showed a smaller amount of NV than the other groups. In particular, 20 mg/kg Perindopril showed 80% inhibition of retinal NV (p<0.001). NPA in the Enalapril and 2 mg/kg Perindopril groups were the same size as those in the Atenolol, Amlodipine, and vehicle groups, but the 20 mg/kg Perindopril group showed much smaller NPA (p=0.001). Conclusion: ACE-I, and especially a high dose of Perindopril, inhibited retinal NV. ACE-I has a direct inhibitory effect on retinal NV and inhibits NV more intensely by reperfusing the retinal NPA when it is administered at a high dose.

Keywords: 483 neovascularization • 566 retinal neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.